Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
about
A review of eslicarbazepine acetate for the adjunctive treatment of partial-onset epilepsyPharmacokinetics and drug interactions of eslicarbazepine acetate.Update on treatment of partial onset epilepsy: role of eslicarbazepineClinical utility of eslicarbazepine: current evidence.Novel medications for epilepsy.Eslicarbazepine acetate for partial-onset seizures.Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.Drug interactions with the newer antiepileptic drugs (AEDs)--Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders.Eslicarbazepine acetate: a review of its use as adjunctive therapy in refractory partial-onset seizures.Pharmacokinetic/pharmacodynamic evaluation of eslicarbazepine for the treatment of epilepsy.Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures.Eslicarbazepine acetate for the treatment of partial epilepsy.Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures.Evaluation of methods for achieving stable INR in healthy subjects during a multiple-dose warfarin study.Lack of effect of lacosamide on the pharmacokinetic and pharmacodynamic profiles of warfarin.
P2860
Q24621327-4B32198B-072F-4E9A-8DB6-C216A5F4606FQ34276263-82AC65D3-01E5-4D7D-9129-E6A7DAC7221FQ34329823-238C1C66-6E23-47E6-AED6-3E429D081BDAQ35087964-88BDF4F2-5B2C-4127-BE75-2D9041784E41Q37950518-8685500C-D53A-4E6E-B2DD-1A9816170F6AQ37957121-8BA5A44B-3D0A-428E-8E0D-148B02EB87EEQ37992162-3F3BEB34-29C8-4E2B-A900-6DC4E5376397Q38116456-F06A54AA-27B3-414C-9C5A-407E6AF837BFQ38223958-8FAD8C09-FD02-44FC-91EF-179BBC2B026EQ38367761-9BBC9ECE-3177-4093-B921-7F142DD56D5DQ38800995-656800B8-1F5A-4D14-9FD8-D7F36208B154Q38826584-867B8681-7D0C-46A4-8166-38E838791751Q39456360-544A80F4-F1E4-416C-9048-7F2975A0673AQ39712065-2EA3528F-052D-4D0B-BD4A-4E2C810D2D96Q45723444-30F39BFC-59F1-47C4-8FC7-2F15F0B530BD
P2860
Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Effect of eslicarbazepine acet ...... ple-dose, single-period study.
@en
type
label
Effect of eslicarbazepine acet ...... ple-dose, single-period study.
@en
prefLabel
Effect of eslicarbazepine acet ...... ple-dose, single-period study.
@en
P2093
P1476
Effect of eslicarbazepine acet ...... iple-dose, single-period study
@en
P2093
Eva Soares
Joana Maia
Manuel Vaz-da-Silva
Patricio Soares-da-Silva
Teresa Nunes
P304
P356
10.1016/J.CLINTHERA.2010.01.014
P577
2010-01-01T00:00:00Z